Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Addition of a Low Fixed Number of CD3 + Cells to CD34-Enriched Allografts: Effects on Engraftment, Graft-versus-Host Disease, and Survival after Related and Unrelated Peripheral Stem Cell Transplantation
2003
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.
2005
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors
2002
Induction of Graft-versus-Host Disease as Immunotherapy for Relapsed Chronic Myeloid Leukemia
1994
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
2004
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias
1995
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Treatment of severe acute graft‐versus‐host disease with anti‐thymocyte globulin
2001
Acute graft-vs-host disease
2001
Age-dependent expression of the erythropoietin gene in rat liver and kidneys.
1992 StandoutNobel
Can Only Partial T-Cell Depletion of the Graft before Hematopoietic Stem Cell Transplantation Mitigate Graft-versus-Host Disease While Preserving a Graft-versus-Leukemia Reaction? A Prospective Phase II Study
2006
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
21q22 balanced chromosome aberrations in therapy‐related hematopoietic disorders: Report from an International Workshop†
2002
Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias
2006 Standout
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
2017
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Determinants of prognosis in late chronic-phase chronic myelogenous leukemia.
1998
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease
2004
Cancer genes and the pathways they control
2004 Standout
Conservation, Variability and the Modeling of Active Protein Kinases
2007 StandoutNobel
Cancer immunotherapy: moving beyond current vaccines
2004 Standout
Adult stem cells in the treatment of autoimmune diseases
2006
Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II–III trial
2005
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Inflammatory Bowel Disease
2002 Standout
Shifting paradigms: the seeds of oncogene addiction
2009
Graft-versus-host disease
2009 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus-Leukemia: Clinical Follow-up and Improved New Vectors
1998
Treatment of hairy-cell leukemia
1990
Therapy-Related Myelodysplastic Syndrome
2007
Chronic Myelogenous Leukemia
2002
OPTIONS FOR THERAPY IN CHRONIC MYELOID LEUKAEMIA
1995
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
2004 Standout
Infectious and immunosuppressive complications of purine analog therapy.
1995
Hematopoietic Stem-Cell Transplantation
2006 Standout
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
2008 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 Standout
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
1993
Combination Antiviral Therapy for Ganciclovir‐Resistant Cytomegalovirus Infection in Solid‐Organ Transplant Recipients
2002
Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype
1998
Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse
2002
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?
2006
Imatinib Mesylate — A New Oral Targeted Therapy
2002
Clonal evolution in cancer
2012 StandoutNature
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants
2001
Chronic Myeloid Leukemia
1999
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
Transfer of the HSV-tk Gene into Donor Peripheral Blood Lymphocytes for In Vivo Modulation of Donor Anti-Tumor Immunity after Allogeneic Bone Marrow Transplantation. The San Raffaele Hospital, Milan, Italy
1995
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia
2001
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment
1991
Embryonic Stem Cells As an Alternate Marrow Donor Source
2004
Current Developments in Cancer Vaccines and Cellular Immunotherapy
2003
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
1997 Science
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Isolating gene-corrected stem cells without drug selection
2005 StandoutNobel
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Correlation of two in vitro tests with clinical response to immunosuppressive therapy in 54 patients with severe aplastic anemia
1984
Patterns of gene expression and the cellular origins of human leukaemias
1978
Induction of Chronic Myelogenous Leukemia in Mice by the P210 bcr/abl Gene of the Philadelphia Chromosome
1990 StandoutScienceNobel
Treatment of severe autoimmune disease by stem-cell transplantation
2005 Nature
Hematopoietic Stem and Progenitor Cells: Clinical and Preclinical Regeneration of the Hematolymphoid System
2002
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
1990
Anomalous phenotype in thymic acute lymphoblastic leukaemia
1980 StandoutNatureNobel
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial
1989
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Multiple Sclerosis
2018 Standout
Course of Crohn's disease after allogeneic marrow transplantation
1998
Graft-versus-leukemia reactions after bone marrow transplantation
1990 Standout
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease
2003
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
T-cell depletion of HLA-identical transplants in leukemia
1991
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
1985 StandoutNature
Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine
1999
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Chronic Myelogenous Leukemia — New Concepts
1981
Chimeric Antigen Receptor Therapy
2018 Standout
Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity
1994
Subsets of Patients with Aplastic Anemia Identified by Flow Microfluorometry
1985 StandoutNobel
Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation
1992
Bone Marrow Transplant
1990 Standout
Homoharringtonine and Low-Dose Cytarabine in the Management of Late Chronic-Phase Chronic Myelogenous Leukemia
2000
Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin
1979 StandoutNobel
Antithymocyte Globulin Treatment in Patients with Aplastic Anemia
1983
Growth Factors and Cancer
1991 StandoutScience
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
1997
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
2000 StandoutScience
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants
2002 StandoutScience
Terminal Transferase as a Predictor of Initial Responsiveness to Vincristine and Prednisone in Blastic Chronic Myelogenous Leukemia
1978 Nobel
Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma
1991
Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis
2001
The Role of B7 Costimulation in CD4/CD8 T Cell Homeostasis
2000 StandoutNobel
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion
1984
Erythropoietin production by the liver in fetal-neonatal life
1975
Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia
1983
Chronic myeloid leukemia: current treatment options
2001
Blast crisis of chronic granulocytic leukemia
1977
Chronic Myelogenous Leukemia: Biology and Therapy
1999
Works of A Marmont being referenced
Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect
2003
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
1989
Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases
2002
The promise of hematopoietic stem cell transplantation for autoimmune diseases
2003
Collection of hematopoietic stem cells from patients with autoimmune diseases
2001
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS
2001
The Treatment of Terminal Metamorphosis of Chronic Granulocytic Leukaemia with Corticosteroids and Vincristine
1973
Treatment‐related leukemia in Hodgkin's disease: A multi‐institution study on 75 cases
1987
Severe Aplastic Anaemia: Correlation of in Vitro Tests with Clinical Response to Immunosuppression in 20 Patients
1981
A New Chromosome Translocation (3;21) in M2 Acute Lymphocytic Leukemia
1986
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase
1988
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]
1993
Immunofluorescent Diagnosis of Acute Lymphoblastic Leukaemia
1975
Pure red cell aplasia (PRCA): Response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis
1975
Allogeneic Bone Marrow Transplantation in Multiple Myeloma
1987
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase [see comments]
1993
Combined foscarnet -ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation (Hsct).
1996
A to O Bone Marrow Transplantation in Severe Aplastic Anaemia: Dynamics of Blood Group Conversion and Demonstration of Early Dyserythropoiesis in the Engrafted Marrow
1977
The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis
2004
Allogeneic bone marrow or peripheral blood cell transplants in adults with hematologic malignancies: a single-center experience.
1998
Stem cell transplantation for severe autoimmune disorders, with special reference to rheumatic diseases.
1997